Viking Pharma’s Tirzepatide delivers a high-purity research-grade formulation designed to support advanced metabolic studies. Each multiple-dose vial contains 10mg per 3ml of the dual incretin mimetic (GLP-1 + GIP), ideal for cutting-edge research applications.
